Views | |
---|---|
Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria | 13 |
October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | |
---|---|---|---|---|---|---|---|
Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria | 0 | 0 | 0 | 0 | 0 | 0 | 13 |
Views | |
---|---|
2022_Terhorst‐Molawi_etal.pdf | 5 |